More tools:Markets·Screener·Research·Chat

iHuman Inc. American depositary shares, each representing five Class A ordinary shares (IH) Financial Statements

iHuman Inc. American depositary shares, each representing five Class A ordinary shares
SIC 6719 · LIFE INSURANCE
FIGI BBG00X71MT63
XNYS · usd
1.24▲ 0.02 (1.23%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.22
Day's Range1.20 – 1.24
52-Week Range1.20 – 3.16
Volume9,005
Avg Volume8,936
Share Statistics
Shares Outstanding
Employees723
ExchangeXNYS
Listed2020-10-09
Share count as of December 31, 2025
Loading Income Statement…
Key questions about iHuman Inc. American depositary shares, each representing five Class A ordinary shares (IH)
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Market Cap?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Market Cap is $631.2M, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Enterprise Value?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Enterprise Value is $466.6M, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Trailing P/E?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Trailing P/E is 46.3×, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Price / Sales?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Price / Sales is 5.5×, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EV / Revenue?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EV / Revenue is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EV / EBITDA?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Revenue (TTM)?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Revenue (TTM) is $115.4M, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Net Income (TTM)?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Net Income (TTM) is $13.6M, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EBITDA?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's EBITDA is $10.7M, based on as-reported figures from SEC (XBRL) filings.
What is iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Diluted EPS (TTM)?
iHuman Inc. American depositary shares, each representing five Class A ordinary shares's Diluted EPS (TTM) is 0.03, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Revenues
Revenues (including transactions with related parties of RMB 1,388, RMB 996 and RMB 932 (US$133) for the years ended December 31, 2023, 2024 and 2025, respectively)
YoY growth-12.5%
Cost of revenues
Cost of revenues (including transactions with related parties of RMB 5,277, RMB 2,735 and RMB 937 (US$134) for the years ended December 31, 2023, 2024 and 2025, respectively)
Gross profit
% of revenue67.9%
Operating expenses
Research and development expenses (including transactions with related parties of RMB 16,264, RMB 13,718 and RMB 11,350 (US$1,625) for the years ended December 31, 2023, 2024 and 2025, respectively)
Sales and marketing expenses (including transactions with related parties of RMB 5,370, RMB 6,021 and RMB 5,317 (US$760) for the years ended December 31, 2023, 2024 and 2025, respectively)
General and administrative expenses (including transactions with a related party of RMB 3,534, RMB 2,833 and RMB 1,905 (US$272) for the years ended December 31, 2023, 2024 and 2025, respectively)
Total operating expenses
% of revenue-59.6%
Operating income
% of revenue8.3%
Other income, net
Income before income taxes
Income tax expenses
Net income
% of revenue11.8%
Basic
Diluted